SCHEMBL12815027

SCHEMBL12815027

O=C(OCc1ccccc1)N1CCC[C@@H](N2CCCCC2=O)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
CYP2C19 P33261 1/20 0.48
TMEM97 Q5BJF2 6/20 0.46
SIGMAR1 Q99720 6/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HTR1A P08908 2/20 0.45
HRH2 P25021 2/20 0.45
HRH1 P35367 2/20 0.45
HRH3 Q9Y5N1 2/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
ADRA2A P08913 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA1D P25100 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4512387 0.97 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL18032527 0.94 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL21193542 0.91 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL21209423 0.91 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL21209410 0.91 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL4872217 0.87 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL23187621 0.87 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL2855664 0.86 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL21041191 0.86 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL31435518 0.84 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011029046-A1 BRUTON'S TYROSINE KINASE INHIBITORS BIOGEN IDEC MA INC. (US) 2011-03-10 WO disclosed